FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2782133571> ?p ?o ?g. }

• W2782133571 endingPage "694" @default.
• W2782133571 startingPage "679" @default.
• W2782133571 abstract "Two major problems in chemotherapy, poor bioavailability of hydrophobic anticancer drug and its adverse side effects causing nausea, are taken into account by developing a sustained drug release vehicle along with enhanced bioavailability using two-dimensional layered double hydroxides (LDHs) with appropriate surface charge and its subsequent embedment in polymer matrix. A model hydrophobic anticancer drug, raloxifene hydrochloride (RH), is intercalated into a series of zinc iron LDHs with varying anion charge densities using an ion exchange technique. To achieve significant sustained delivery, drug-intercalated LDH is embedded in poly(ε-caprolactone) (PCL) matrix to develop intravenous administration and to improve the therapeutic index of the drug. The cause of sustained release is visualized from the strong interaction between LDH and drug, as measured through spectroscopic techniques, like X-ray photoelectron spectroscopy, infrared, UV–visible spectroscopy, and thermal measurement (depression of melting temperature and considerable reduction in heat of fusion), using differential scanning calorimeter, followed by delayed diffusion of drug from polymer matrix. Interestingly, polymer nanohybrid exhibits long-term and excellent in vitro antitumor efficacy as opposed to pure drug or drug-intercalated LDH or only drug embedded PCL (conventional drug delivery vehicle) as evident from cell viability and cell adhesion experiments prompting a model depicting greater killing efficiency (cellular uptake) of the delivery vehicle (polymer nanohybrid) controlled by its better cell adhesion as noticed through cellular uptake after tagging of fluorescence rhodamine B separately to drug and LDH. In vivo studies also confirm the sustained release of drug in the bloodstream of albino rats using polymer nanohybrid (novel drug delivery vehicle) along with a healthy liver vis-à-vis burst release using pure drug/drug-intercalated LDHs with considerable damaged liver." @default.
• W2782133571 created "2018-01-12" @default.
• W2782133571 creator A5005379720 @default.
• W2782133571 creator A5009642178 @default.
• W2782133571 creator A5021275037 @default.
• W2782133571 creator A5030905907 @default.
• W2782133571 creator A5054143365 @default.
• W2782133571 creator A5054953267 @default.
• W2782133571 date "2018-01-18" @default.
• W2782133571 modified "2023-09-25" @default.
• W2782133571 title "Engineered Cellular Uptake and Controlled Drug Delivery Using Two Dimensional Nanoparticle and Polymer for Cancer Treatment" @default.
• W2782133571 cites W1414886268 @default.
• W2782133571 cites W1757407923 @default.
• W2782133571 cites W1984418916 @default.
• W2782133571 cites W1990782969 @default.
• W2782133571 cites W1993596800 @default.
• W2782133571 cites W1998899314 @default.
• W2782133571 cites W2001966234 @default.
• W2782133571 cites W2002528172 @default.
• W2782133571 cites W2006989595 @default.
• W2782133571 cites W2007853971 @default.
• W2782133571 cites W2008817603 @default.
• W2782133571 cites W2011090397 @default.
• W2782133571 cites W2038360548 @default.
• W2782133571 cites W2044090247 @default.
• W2782133571 cites W2046605287 @default.
• W2782133571 cites W2054927838 @default.
• W2782133571 cites W2063714693 @default.
• W2782133571 cites W2068790794 @default.
• W2782133571 cites W2068969213 @default.
• W2782133571 cites W2069631908 @default.
• W2782133571 cites W2072155526 @default.
• W2782133571 cites W2078353661 @default.
• W2782133571 cites W2080202676 @default.
• W2782133571 cites W2080757115 @default.
• W2782133571 cites W2083401755 @default.
• W2782133571 cites W2083430754 @default.
• W2782133571 cites W2086689650 @default.
• W2782133571 cites W2100372768 @default.
• W2782133571 cites W2103406964 @default.
• W2782133571 cites W2123816005 @default.
• W2782133571 cites W2128957216 @default.
• W2782133571 cites W2135582663 @default.
• W2782133571 cites W2144066323 @default.
• W2782133571 cites W2156895262 @default.
• W2782133571 cites W2158558808 @default.
• W2782133571 cites W2170147411 @default.
• W2782133571 cites W2170755857 @default.
• W2782133571 cites W2234540111 @default.
• W2782133571 cites W2327637082 @default.
• W2782133571 cites W2470636241 @default.
• W2782133571 cites W2533619707 @default.
• W2782133571 cites W2556271573 @default.
• W2782133571 cites W2564885194 @default.
• W2782133571 cites W2578455328 @default.
• W2782133571 cites W2626558946 @default.
• W2782133571 cites W2755738053 @default.
• W2782133571 cites W2766624303 @default.
• W2782133571 cites W768776898 @default.
• W2782133571 doi "https://doi.org/10.1021/acs.molpharmaceut.7b01119" @default.
• W2782133571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29298488" @default.
• W2782133571 hasPublicationYear "2018" @default.
• W2782133571 type Work @default.
• W2782133571 sameAs 2782133571 @default.
• W2782133571 citedByCount "46" @default.
• W2782133571 countsByYear W27821335712018 @default.
• W2782133571 countsByYear W27821335712019 @default.
• W2782133571 countsByYear W27821335712020 @default.
• W2782133571 countsByYear W27821335712021 @default.
• W2782133571 countsByYear W27821335712022 @default.
• W2782133571 countsByYear W27821335712023 @default.
• W2782133571 crossrefType "journal-article" @default.
• W2782133571 hasAuthorship W2782133571A5005379720 @default.
• W2782133571 hasAuthorship W2782133571A5009642178 @default.
• W2782133571 hasAuthorship W2782133571A5021275037 @default.
• W2782133571 hasAuthorship W2782133571A5030905907 @default.
• W2782133571 hasAuthorship W2782133571A5054143365 @default.
• W2782133571 hasAuthorship W2782133571A5054953267 @default.
• W2782133571 hasConcept C12554922 @default.
• W2782133571 hasConcept C155672457 @default.
• W2782133571 hasConcept C161790260 @default.
• W2782133571 hasConcept C171250308 @default.
• W2782133571 hasConcept C178790620 @default.
• W2782133571 hasConcept C181389837 @default.
• W2782133571 hasConcept C185592680 @default.
• W2782133571 hasConcept C192562407 @default.
• W2782133571 hasConcept C202751555 @default.
• W2782133571 hasConcept C2778002958 @default.
• W2782133571 hasConcept C2779820397 @default.
• W2782133571 hasConcept C2780035454 @default.
• W2782133571 hasConcept C521977710 @default.
• W2782133571 hasConcept C53227056 @default.
• W2782133571 hasConcept C55493867 @default.
• W2782133571 hasConcept C71924100 @default.
• W2782133571 hasConcept C86803240 @default.
• W2782133571 hasConcept C98274493 @default.
• W2782133571 hasConceptScore W2782133571C12554922 @default.
• W2782133571 hasConceptScore W2782133571C155672457 @default.

• next